Archive for November 2019
Cabot Corp. plans layoff at Atlanta-area office, moving jobs to Latvia
Cabot will relocate many of its Alpharetta Business Services functions and roles to the company’s shared service center in Riga, Latvia. Read More
Read MoreWith new Hyannis HQ, Cape Cod Five aims to attract talent from over the bridge
The CEO of The Cape Cod Five Cents Savings Bank hopes the company’s shiny new headquarters will help attract new talent from around the Cape and the Islands, as well as from the mainland over the bridges. Read More
Read MoreInsurers, physician groups again avoid tougher scrutiny from health care watchdog
For the fourth year in a row, the state’s health care watchdog declined to hold specific insurers and doctors groups to task on their spending, despite seeing continued growth in health care expenditures. Read More
Read MoreSuperpedestrian raises $20M for its fleet of self-maintaining e-scooters
Cambridge-based micro-mobility startup Superpedestrian raised $20 million to finance the production and rollout of its “ultra-safe” scooter fleet. Spark Capital, General Catalyst, Hanaco Ventures and Empire Angels participated in the round. Read More
Read MoreFDA gives early OK to Alnylam rare disease drug
The FDA has approved Alnylam’s new product Givlaari, which silences the gene behind a rare metabolic disease. Read More
Read MoreChiofaro proposes $1B, 600-foot downtown Boston tower
The proposal follows seven years of planning. Read More
Read MoreNortheastern pitches new 29-story dorm
The project represents Northeastern’s second partnership with Austin, Texas-based American Campus Communities — and stands in stark contrast to the British dorm developer that changed its plans to develop apartments instead of student housing. Read More
Read MoreFive things you need to know today, and what about OK, Gen Xer?
Good morning — here are the5 Things You Need to Know in local business news, plus Fidelity, history facts, worst toys, and what this Gen Xer thinks about "OK Boomer" Read More
Read MoreKeytruda researcher launches cancer-focused Werewolf Therapeutics with $56M
The company is founded and led by MPM Capital partner and cancer researcher Daniel Hicklin, who oversaw the development of Merck’s immuno-oncology drug Keytruda and other cancer products. Read More
Read MoreThese airports offer the cheapest domestic flights
A recent study ranked 45 U.S. airports based on the average price of airfare for a domestic flight. Here’s where you can get the most bang for your buck. Read More
Read More